According to the CDC, more than 28 million Americans are living with heart disease, the leading killer of both men and women in the country. While individuals can lower their risk for heart disease through healthy diet and exercise, medical innovation might drastically reduce the scourge of heart disease in the United States. But, where is the national urgency in addressing this crisis?
What are the demographic, economic and medical barriers to reducing heart disease? How can technology, like biometric monitoring and genetic testing, promise tangible results in improving heart health? What’s the heart health moonshot for the decade ahead? And what can individual cardiologists do to spark change in their own hospitals or practices?
The Atlantic assembled the leading voices on heart health in Orlando, FL for an Atlantic Exchange that questioned the status quo and looked toward the future of this critical field.
Clinical Professor of Medicine, Cedars-Sinai Smidt Heart Institute
Staff writer, The Atlantic
Director, Cardiac Catheterization Laboratories, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center
Director, Preventive Intervention Center, College of Public Health and Department of Epidemiology, University of Iowa
President, Mended Hearts
Unlock unlimited access to The Atlantic, including exclusive events for subscribers. Join us today and help ensure a bright future for independent journalism.
SubscribeEmily Akhtarzandi, Managing Director, AtlanticLIVE
John Tsai, Senior Vice President, Global Medical and Chief Medical Officer, Amgen*
Clinical Professor of Medicine, Cedars-Sinai Smidt Heart Institute
Staff writer, The Atlantic
Director, Cardiac Catheterization Laboratories, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center
Director, Preventive Intervention Center, College of Public Health and Department of Epidemiology, University of Iowa
President, Mended Hearts
Emily Akhtarzandi, AtlanticLIVE
Friday, March 9, 2018
4:30 pm EDT